top of page

The abstract submission period has ended on 16 July.

PCCS 2023
Abstract
Submission
Guidance

  • Abstracts must be in English

  • Abstract must be original and not presented nor published elsewhere

  • Maximum length of 300 words (excludes title, authors/designations, references, and figures/images/tables also)

  • A maximum of 2 tables, figures, or images should be included in the abstract

  • References in Vancouver style (no limit to number of references)

  • Funding sources or other acknowledgements should be also declared, as should conflict of Interest, where prompted under “Disclosures to declare”.

  • Abstracts received after the deadline will not be considered.

  • The abstract itself must be anonymised as it does not identify the submitting individual(s) or their affiliation(s).

  • There is no limit to the number of abstracts an individual can submit, but all named authors must have had a significant contribution to the work undertaken

  • Abstract outlines (Non-case reports):

    • Background and aims

    • Methods

    • Results

    • Discussion and conclusion(s)

  • Abstract outlines (Case reports):

    • Background

    • Case summary

    • Key learning points

    • Why this case report is of value

General Terms of Submission

  • The decision of the Reviewers on the acceptability of the submission is final.

  • No correspondence on their decision can be initiated by the author(s) or submitter.

  • ALL PRESENTING AUTHORS MUST REGISTER AS DELEGATES WITHOUT EXCEPTION and the submission of an abstract serves as confirmation of the presenter’s availability to attend and pay for being at the Conference.

  • All abstracts will be acknowledged via the online system. If you have not had a confirmation of receipt within 7 days of your submission, please contact us.

  • Instructions on the timings and duration of oral presentations and the format of posters will be given in the result correspondence. If you have not received a result by the end of July 2023, please contact us. If an abstract cannot be presented at the Conference, the Secretariat must be notified in writing in advance to avoid compromise to the professionalism of the event.

  • The PCCS 2023 Reviewers reserve the right to accept or refuse an abstract, to designate abstracts as either oral or poster presentations and to choose a suitable session for the abstract.
     

Declaration of Consent to Publication and Assignation of Copyright

By submitting an abstract the authors collectively accept the following:

​I confirm that I checked this abstract before submission and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted. Submission of the abstract constitutes my consent to publication (e.g. conference website, programs, other promotions, etc.) The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content (“Content”) provided to PCCS 2023 Conference and Paediatric Critical Care Society in the UK (Hereafter: “The Organisers”). The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights. The Abstract Submitter grants the Organisers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content. The Organisers reserve the right to remove from any publication an abstract which does not comply with the above. The corresponding author is responsible for informing the other authors about the status of the abstract.

PCCS Scot23 web background graphics 1920x1080 -7.png

The PCCS SG Committee and Local Scientific Committee will have final decision on allocation of accepted abstracts for either poster or oral presentation.

bottom of page